We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+7.66%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$455B
AUM Growth
+$26.6B
Cap. Flow
-$26.7B
Cap. Flow %
-5.87%
Top 10 Hldgs %
33.25%
Holding
16,292
New
1,467
Increased
6,223
Reduced
6,687
Closed
1,652

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$645M
2
TMUS icon
T-Mobile US
TMUS
+$640M
3
T icon
AT&T
T
+$517M
4
HUM icon
Humana
HUM
+$481M
5
BSX icon
Boston Scientific
BSX
+$400M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.24B
2
AAPL icon
Apple
AAPL
+$755M
3
META icon
Meta Platforms (Facebook)
META
+$707M
4
CAT icon
Caterpillar
CAT
+$472M
5
AMD icon
Advanced Micro Devices
AMD
+$449M

Sector Composition

Rank Sector Weight
1 Healthcare 3.33%
2 Technology 3.18%
3 Financials 2.22%
4 Industrials 2.17%
5 Consumer Discretionary 2.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCV
15776
DELISTED
Churchill Capital Corp V
CCV
-23,361
Closed -$232K
CCV
15777
PUT
DELISTED
Churchill Capital Corp V
CCV
-30,200
Closed -$300K
ZYNE
15778
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
-17,471
Closed -$9.21K
ZYNE
15779
PUT
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
-8,100
Closed -$4.29K
JIDA
15780
DELISTED
JPMorgan ActiveBuilders International Equity ETF
JIDA
-5,199
Closed -$211K
FFSG
15781
DELISTED
FormulaFolios Smart Growth ETF
FFSG
-17,164
Closed -$527K
FZT
15782
DELISTED
FAST Acquisition Corp. II
FZT
-717,607
Closed -$7.18M
KLR
15783
CALL
DELISTED
Kaleyra, Inc.
KLR
-3,829
Closed -$10.1K
KLR
15784
DELISTED
Kaleyra, Inc.
KLR
-1,383
Closed -$3.65K
KLR
15785
PUT
DELISTED
Kaleyra, Inc.
KLR
-2,086
Closed -$5.51K
VQS
15786
DELISTED
VIQ SOLUTIONS INC
VQS
-66,298
Closed -$17.4K
VQS
15787
PUT
DELISTED
VIQ SOLUTIONS INC
VQS
-1,000
Closed -$263
MPRA
15788
DELISTED
Mercato Partners Acquisition Corporation Class A Common Stock
MPRA
-312,500
Closed -$3.21M
EBET
15789
DELISTED
EBET, INC. Common Stock
EBET
-1,438
Closed -$24.1K
EBET
15790
PUT
DELISTED
EBET, INC. Common Stock
EBET
-1,637
Closed -$30.9K
FATH
15791
PUT
DELISTED
Fathom Digital Manufacturing Corporation
FATH
-265
Closed -$7K
ICNC
15792
DELISTED
Iconic Sports Acquisition Corp.
ICNC
-393,095
Closed -$4.06M
DBTX
15793
CALL
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
-76,100
Closed -$156K
DBTX
15794
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
-1,787,311
Closed -$3.66M
DBTX
15795
PUT
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
-1,700
Closed -$3.48K
BRDS
15796
CALL
DELISTED
Bird Global, Inc.
BRDS
-356
Closed -$1.6K
BRDS
15797
DELISTED
Bird Global, Inc.
BRDS
-1,600
Closed -$7.21K
BRDS
15798
PUT
DELISTED
Bird Global, Inc.
BRDS
-16
Closed -$72
PRTK
15799
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
-203,159
Closed -$401K
ZEV.WS
15800
DELISTED
Lightning eMotors, Inc. Redeemable Warrants, each whole warrant exercisable 1/20th of a share of common stock at an exercise price of $230.00 per whole share
ZEV.WS
-11,155
Closed -$433

Similar funds

Ken Griffin's Q1 2023 Portfolio in Review

As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.

  • Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
  • Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
  • Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
  • Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
  • Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
  • Ken Griffin opened 1,467 new positions and closed 1,652 in Q1 2023.
  • Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.